Related Experiment Video
Updated: May 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Assessment of antibiotic prophylaxis post cardiac implantable electronic device implantation: a retrospective cohort
Sarah Aljohani1, Lama Alfehaid2,3,4, Meshary Almeshary3,4
1Pharmaceutical Care Department, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Insights
Postoperative prophylactic antibiotics for cardiac implantable electronic devices (CIEDs) showed no significant difference in infection rates. Further research is needed to confirm these findings for CIED infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Technology
Background:
- Cardiac implantable electronic devices (CIEDs) are crucial for managing arrhythmias and preventing sudden cardiac death.
- CIED-related infections are an increasing concern.
- The role of postoperative prophylactic antibiotics in preventing CIED infections remains debated.
Purpose of the Study:
- To assess current practices of postoperative prophylactic antibiotic use in CIED recipients.
- To determine the incidence of CIED infections in relation to postoperative antibiotic administration.
Main Methods:
- A retrospective cohort study was conducted at King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- The study included 200 adult patients who underwent CIED implantation between 2017 and 2022.
- Infection rates post-antibiotic prophylaxis were the primary outcome, analyzed using Stata 18.5.
Main Results:
- The cohort (n=200) had a median age of 64 years, with common comorbidities including hypertension and diabetes.
- All patients received pre-operative antibiotics; 95% received postoperative antibiotics.
- A low rate of infection was observed (0.5% definite, 1.5% possible), with no infections in the small group (n=10) not receiving postoperative antibiotics. Exploratory analysis showed no difference in infection rates based on duration or single-agent vs. combination therapy.
Conclusions:
- Current prophylactic antibiotic strategies (≤7 days or single agent) did not show a detectable difference in CIED infection rates.
- Larger prospective studies, including a control group not receiving prophylactic antibiotics, are necessary to definitively compare infection rates.
Background:
Cardiac implantable electronic devices (CIEDs) manage arrhythmias and prevent sudden cardiac death, but related infections are rising. Pre-implantation antibiotics lower infection rates, while postoperative use is debated.
Purpose:
To evaluate current postoperative prophylactic antibiotic practices and CIED infection rates.
Method:
A retrospective cohort study at King Abdulaziz Medical City (KAMC), Riyadh, Saudi Arabia, included adults > 18 who underwent CIED implantation from 2017 to 2022. The primary outcome measured infection rates post-antibiotic prophylaxis. Data were analyzed using Stata 18.5.
Results:
The study included 200 patients, predominantly male (62%), with a median age of 64 years. Common comorbidities included hypertension (71.5%), diabetes (65.5%), and heart failure (64%). All patients received pre-operative antibiotics, primarily cefazolin (88.4%) and vancomycin (6.5%). Most patients (95%) received postoperative antibiotics, most commonly amoxicillin/clavulanic acid (83.6%), while 14% received combination therapy. Among patients who received postoperative antibiotics (n = 190), 1 definite infection (0.5%) and 3 possible infections (1.5%) were observed, with no infections identified among those who did not receive postoperative antibiotics (n = 10). Regarding duration, possible infections occurred in 1.0% of patients receiving antibiotics for more than 7 days and 2.3% of those receiving 7 days or less. In the regimen analysis, definite infection occurred in 0.6% of patients receiving single-agent therapy and none in those receiving combination therapy. Given the low number of events, these findings are descriptive and should be interpreted as exploratory.
Conclusion:
Prophylactic antibiotics for 7 days or less, or a single agent, was not associated with a detectable difference in infection rates. A larger prospective study including patients not receiving prophylactic antibiotics post-implantation is needed to distinguish infection rates between those who did and did not receive them.
Clinical Trial Number:
Not applicable.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Cardiac Catheterization I: Pre-Procedure Overview
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management

